Cargando…
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
BACKGROUND: CDK-inhibitors can diminish transcriptional levels of cell cycle-related cyclins through the inhibition of E2F family members and CDK7 and 9. Cyclin A1, an E2F-independent cyclin, is strongly upregulated under genotoxic conditions and functionally was shown to increase NHEJ activity. Cyc...
Autores principales: | Federico, Mario, Symonds, Catherine E, Bagella, Luigi, Rizzolio, Flavio, Fanale, Daniele, Russo, Antonio, Giordano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224749/ https://www.ncbi.nlm.nih.gov/pubmed/20684776 http://dx.doi.org/10.1186/1476-4598-9-208 |
Ejemplares similares
-
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
por: Benson, C, et al.
Publicado: (2007) -
Non-Linear Pharmacokinetics of Oral Roscovitine (Seliciclib) in Cystic Fibrosis Patients Chronically Infected with Pseudomonas aeruginosa: A Study on Population Pharmacokinetics with Monte Carlo Simulations
por: Leven, Cyril, et al.
Publicado: (2020) -
Different DNA End Configurations Dictate Which NHEJ Components Are Most Important for Joining Efficiency
por: Chang, Howard H. Y., et al.
Publicado: (2016) -
Beta Human Papillomavirus 8E6 Attenuates Non-Homologous End Joining by Hindering DNA-PKcs Activity
por: Hu, Changkun, et al.
Publicado: (2020) -
Characterization of Cyclin E Expression in Multiple Myeloma and Its Functional Role in Seliciclib-Induced Apoptotic Cell Death
por: Josefsberg Ben-Yehoshua, Liat, et al.
Publicado: (2012)